Stay updated with breaking news from Aker Superba. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.
Aker BioMarine ASA is consolidating intellectual property (IP) in the krill space, with the announcement that it has acquired krill-related patents, pre-clinical and clinical data, and processing equipment from Acasti Pharma Inc.
Premium prices being paid by Chinese consumers for krill-based health products suggest strong revenue growth for Oslo, Norway-based Aker BioMarine.